ERSTX
Price
$26.65
Change
+$0.11 (+0.41%)
Updated
Jul 3 closing price
Net Assets
1.42B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

ERSTX vs VVIAX

Header iconERSTX vs VVIAX Comparison
Open Charts ERSTX vs VVIAXBanner chart's image
Eaton Vance Large-Cap Value R
Price$26.65
Change+$0.11 (+0.41%)
VolumeN/A
Net Assets1.42B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
ERSTX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ERSTX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERSTX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. ERSTX (1.42B). VVIAX pays higher dividends than ERSTX: VVIAX (2.18) vs ERSTX (0.71). ERSTX was incepted earlier than VVIAX: ERSTX (21 years) vs VVIAX (25 years). ERSTX (1.25) is less costly to investors than VVIAX (0.05). ERSTX is a more actively managed with annual turnover of: 75.00 vs. VVIAX (9.00). ERSTX has a lower initial minimum investment than VVIAX: ERSTX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. ERSTX (7.09). VVIAX return over 5 years is better than : 80.13 vs. ERSTX (57.04).
ERSTXVVIAXERSTX / VVIAX
Total Expense Ratio1.250.052,500%
Annual Report Gross Expense Ratio1.250.052,500%
Fund Existence21 years25 years-
Gain YTD5.8146.19894%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.42B189B1%
Annual Yield % from dividends0.712.1833%
Returns for 1 year7.0912.0359%
Returns for 3 years22.9735.1765%
Returns for 5 years57.0480.1371%
Returns for 10 years50.18115.6743%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.